Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-09

Clinical Trial Update: Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders [NA]

View source ↗

Summary

The completed clinical trial evaluated the efficacy of prebiotic and probiotic dietary modulation in schizophrenia, sponsored by Universidad de Córdoba.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidad de Córdoba | Conditions: Schizophrenia and Related Disorders, Diet Habit | NA | Status: COMPLETED